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Background: A total of 2,514,346 metric tons (Mt) of asbestos were imported into Spain from 1906 until the ban
on asbestos in 2002. Our objective was to study pleural cancer mortality trends as an indicator of mesothelioma
mortality and update mortality predictions for the periods 2011–2015 and 2016–2020 in Spain.
Methods: Log-linear Poisson models were fitted to study the effect of age, period of death and birth cohort (APC)
on mortality trends. Change points in cohort- and period-effect curvatures were assessed using segmented regres-
sion. Fractional power-link APC models were used to predict mortality until 2020. In addition, an alternative model
based on national asbestos consumption figures was also used to perform long-term predictions.
Results: Pleural cancer deaths increased across the study period, rising from 491 in 1976–1980 to 1,249 in 2006–2010.
Predictions for the five-year period 2016–2020 indicated a total of 1,319 pleural cancer deaths (264 deaths/year).
Forecasts up to 2020 indicated that this increase would continue, though the age-adjusted rates showed a
levelling-off in male mortality from 2001 to 2005, corresponding to the lower risk in post-1960 generations.
Among women, rates were lower and the mortality trend was also different, indicating that occupational exposure was
possibly the single factor having most influence on pleural cancer mortality.
Conclusion: The cancer mortality-related consequences of human exposure to asbestos are set to persist and remain
in evidence until the last surviving members of the exposed cohorts have disappeared. It can thus be assumed that
occupationally-related deaths due to pleural mesothelioma will continue to occur in Spain until at least 2040.
Keywords: Age-period-cohort, Asbestos, Epidemiology, Pleural cancer, MesotheliomaBackground
Pleural cancer mortality is an acknowledged indicator of
exposure to asbestos and mesothelioma mortality [1],
and since the 1960s mesothelioma has been gaining
interest world-wide as a result of its increasing inci-
dence, related medico-legal issues and poor prognosis
[2]. Pleural cancer can rapidly prove fatal, as it has five-
and ten-year relative survival rates of 6.8% and 2.5% re-
spectively [3]. Most mesotheliomas are due to exposure
to asbestos, with 80%-85% of cases being attributable to* Correspondence: glabente@isciii.es
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distribution, and reproduction in any mediumoccupational exposure [4]. Increased risk has been re-
ported for workers employed in asbestos mines, asbestos
plants, the installation and manufacture of insulation
materials, the production of anti-gas masks, shipyards,
railways and other occupations involving inhalation of
asbestos dust [4-6].
From 1906 until 2002, the year in which asbestos was
banned, a total of 2,514,391 Mt of asbestos were
imported into Spain, with a halt in imports during the
years of the Spanish Civil War (1936–1939). In view of
the country’s lack of domestic production, import data
are the best indicator of asbestos consumption in Spain.
The vast majority of the imported asbestos was in raw
form (fibre, dust) and was earmarked for manufacturing
products, ranging from cement, insulation and textiles
to ships and automobiles. Imports increased steadilyCentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
López-Abente et al. BMC Cancer 2013, 13:528 Page 2 of 8
http://www.biomedcentral.com/1471-2407/13/528from 1906 until 1974 and peaked in the five-year period
1973–1977, with an average of 113,921 tons per year
and a maximum of 130,293 tons in 1974 [7]. This figure
was slightly lower than that recorded in 1975 for neigh-
bouring countries, such as Italy (132,184 Mt), France
(136,587 Mt) and the United Kingdom (137,487 Mt) [8].
In Spain, as in Italy and France, imports decreased
gradually from 1980 onwards, while in other countries
such as the USA, Australia, United Kingdom and
Scandinavia, the decline began some 10 to 20 years
earlier [9].
In terms of the number of workers exposed in Spain,
in 1971 initial estimates put the number of exposed sub-
jects at 8,000, 70% in the fibre-cement sector [10]. In
1991, the National Institute for Health & Safety in the
Workplace (Instituto Nacional de Seguridad e Higiene
en el Trabajo) estimated the number of exposed workers
at 60,488 [11], while the CAREX (CARcinogen EXPos-
ure) project estimated this figure as being 56,600 by the
end of 1990s [12]. Moreover, in December 2008 the
Comprehensive National Health Surveillance Programme
of Workers exposed to asbestos in Spain (Programa Inte-
gral de Vigilancia de Salud de Trabajadores Expuestos a
Amianto en España/PIVISTEA) included a total of 22,158
workers from 14 Autonomous Regions (Comunidades
Autónomas) and 306 companies [13].
Neighbouring countries have drawn up mesothelioma
mortality predictions, which are periodically updated
[2,9,14,15]. These predictions are based on age-period-
cohort analyses of pleural cancer mortality and the
examination of its association with asbestos consump-
tion [9,16]. The updating of predictions is a result of the
extreme sensitivity of the models to the introduction of
the most recent data. A pleural cancer mortality forecast
was recently published (2008) in Spain covering the
period 2002–2016 [17].
Accordingly, the aim of this study was to analyse
pleural cancer mortality for the purpose of: 1) analysing
changes in period and cohort effects on pleural cancer
mortality; and, 2) updating predictions of pleural cancer
and pleural mesothelioma mortality for the five-year
periods 2011–2015 and 2016–2020, using the age-
period-cohort approach and national asbestos imports
as an indicator of exposure.
Methods
Mortality and population data
Mortality data were drawn from the records of the Na-
tional Statistics Institute (Instituto Nacional de Estadística/
INE) for the study period (1976–2010), and corresponded
to deaths coded as malignant pleural neoplasm, namely,
codes 163 (International Classification of Diseases-9th Re-
vision/ICD-9) and C38.4, C45.0 (ICD-10). Midyear popula-
tions and projections for the periods 2011–2015 and2016–2020 were likewise obtained from the National Sta-
tistics Institute.
Age-period-cohort (APC) models
Log-linear Poisson models were fitted to study the effect
of age, period of death and birth cohort. Five-year age
groups (35–39 to 85+ years) and periods were used
(1976–80, 1981–85,…, 2006–10). To address the “non-
identifiability” problem (the three factors, i.e., age, period
and cohort, are linearly dependent), we used the evalu-
ation of estimable parameters proposed by Holford [18],
such as the curvature in each effect and the sum of
period and cohort linear slopes, also known as net drift.
Age groups <35 years were excluded from this analysis,
due to the limited number of deaths in these age groups.
We checked for extra-Poisson dispersion [19], and ef-
fects were calculated using a negative binomial distri-
bution. Specific functions for all these analyses were
written in R [20].
Curvature change points
The presence of points of change in the curvatures of
the cohort and period effects was evaluated using seg-
mented regression. Details of the recursive algorithm
used to estimate the segmented regression have been
published elsewhere, and the procedure can be easily ap-
plied using the R package “segmented” [21]. These models
were fitted to the relationship between curvature effects
and time, thereby enabling the change points to be identi-
fied and their confidence intervals calculated.
Age-period-cohort prediction model
Prediction age-period-cohort models with 1/5-power
link and Poisson variance [22] were fitted to the ob-
served pleural cancer death rates by 5-year age groups
(35–39 to 85+ years) and seven calendar periods (1976–
1980 to 2006–2010). Instead of the usual log link, the
fractional-power link was used to level off the exponential
growth in rates over time resulting from the standard log-
linear model. The number of deaths from pleural cancer
in each 5-year age group for the upcoming five-year pe-
riods 2011–2015 and 2016–2020 was predicted from the
above model, by putting curvatures for future periods and
cohorts equal to the last curvatures estimated from the
model, and projecting the drift over time. Since the in-
creasing drift attenuated gradually over the observed study
period (Figure 1), we projected the linear slope between
the two most recent 5-year periods, rather than the overall
net drift, to emphasise recent trends. In addition, this lin-
ear slope was reduced by 25% in projecting the period
2016–2020, to account for an eventual deceleration in
long-term trends. The lower age limit was chosen so that
there would be cases in all periods. For age groups below
this limit, future rates were estimated using the observed
Figure 1 Age-adjusted pleural cancer mortality rates (1976–2010) and predictions (2011–2020) in Spain.
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dictions were performed for men and women, jointly and
separately, using the Nordpred R statistical software
package [22].
Asbestos-consumption-based prediction model
Since most pleural cancers are mesotheliomas specific-
ally linked to occupational asbestos exposure, a model
based on national asbestos consumption figures was also
used to perform long-term predictions of the annual
number of deaths from pleural cancer among Spanish
men over the period 2012–2038. In view of the negli-
gible domestic production and export of asbestos in
Spain, annual per capita asbestos consumption was de-
termined as annual imports of raw asbestos in any form
from 1906 to 2002 divided by the corresponding midyear
Spanish population. Data on asbestos imports in Spain
were obtained from several sources: primarily from a
compilation made by the Catalonian Regional Labour
Authority and from a report entitled, “Foreign trade
statistics for Spain”, which compiled annual asbestos
import and export figures; and also from company
records [7,23].
A locally-weighted, running-line smoother with 10%
bandwidth (proportion of points in the plot which influ-
ence the smoother at each value) was applied to this as-
bestos consumption series, in order to smooth out
short-term fluctuations and highlight long-term con-
sumption trends [24]. To develop the prediction model,
the annual number of male pleural cancer deaths from
1975 to 2011 was regressed (ordinary least squares re-
gression analysis) on the smoothed annual per-capita as-
bestos consumption using different exposure lag periods
from 30 to 40 years in 1-year increments. Different
functional relationships were also used, including lin-
ear and quadratic terms for the untransformed andlog-transformed exposure, identity and log links for
the mean response, and additive normally distributed
errors. From among the different exposure lags and
functional relationships, we selected the prediction
model with the lowest Akaike Information Criterion
(AIC). Note that the likelihood functions, and hence
the AIC statistics, were comparable across all fitted
models, since the mean response was transformed through
the log link function, rather than log-transforming the re-
sponse variable itself [25]. The model chosen was used to
predict the annual number of male pleural cancer deaths
across the upcoming period 2012–2038, based on the pre-
ceding national asbestos consumption figures [9].
Results
From 1975 to 2010, there were 6,037 pleural cancer
deaths in Spain, with the breakdown showing 3,986
(66%) in men and 2,051 (34.0%) in women. The male/fe-
male ratio rose from 1.1 in 1975 to 2.5 in 2010.
Observed and predicted (APC model) pleural cancer
deaths in both sexes by age group and period of death
are shown in Table 1. Predicted deaths for the period
2011–2020 ranged from 257 to 265 deaths per year
(187–193 among men). Predictions for 2016–2020 indi-
cate a total of 1319 pleural cancer deaths. Figure 1 de-
picts the trend in age-adjusted rates and predictions
(dashed line) (both sexes; men; and women): the age-
adjusted rates showed a levelling-off from the period
2001–2005 among men, and a gradual decline from the
1980s onwards among women. Predictions for the pe-
riods 2011–2015 and 2016–2020 maintain the general
trend in age-adjusted rates in both men and women.
The deviance changes in the sequential building of the
models, the trend in age-specific death rates and the re-
sults for age, period, and cohort effects in men are all
depicted in Figure 2a. Whereas the cohort-effect curvature
Table 1 Observed pleural cancer deaths by age-groups and period of death (1976–2010) and predicted (2011–2020) in
Spain
Age group 1976-80 1981-85 1986-90 1991-95 1996-00 2001-05 2006-10 2011-15+ 2016-20+
0-4 0 0 1 0 1 0 0 0.0 0.0
5-9 1 1 0 0 0 0 0 0.0 0.0
10-14 0 1 0 0 1 0 0 0.0 0.0
15-19 2 2 0 1 1 0 0 0.0 0.0
20-24 1 2 2 2 1 1 0 0.4 0.4
25-29 5 1 4 3 3 2 2 1.6 1.3
30-34 9 3 12 10 0 2 4 2.8 2.2
35-39 11 6 7 9 8 6 3 3.1 2.8
40-44 9 12 17 8 30 17 5 5.7 5.8
45-49 19 23 19 41 30 36 32 15.1 11.8
50-54 46 51 41 59 52 61 55 58.9 30.9
55-59 52 60 68 74 79 99 91 100.1 88.3
60-64 66 81 94 112 110 108 146 127.8 143.7
65-69 82 83 109 110 158 142 159 183.7 164.8
70-74 84 109 98 143 172 209 184 201.6 238.8
75-79 67 98 91 119 157 200 260 219.5 231.9
80-84 26 67 63 105 81 149 167 205.6 193.5
85+ 11 21 33 58 73 95 141 158.0 209.9
Total deaths 491 621 659 854 957 1127 1249 1283.9 1326.1
Age-adjusted rates§ per 100,000 0.283 0.322 0.317 0.376 0.387 0.403 0.396 0.377 0.350
Men
Deaths 265 346 407 557 676 796 897 933.9 964.3
Age-adjusted rates per 100,000 0.347 0.410 0.446 0.566 0.622 0.648 0.644 0.620 0.577
Women
Deaths 226 275 252 297 281 331 352 345.1 354.5
Age-adjusted rates per 100,000 0.233 0.252 0.215 0.219 0.195 0.203 0.196 0.177 0.163
Men
Predicted deaths from asbestos import model 291.7 338.5 425.8 508.7 670.1 824.9 902.4 892.8 787.9
§ Age-adjusted rates with european standard population.
+Predicted deaths and age-adjusted rates (in bold) obtained from the fractional-power link APC models.
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case with the period-effect curvature (p = 0.28). Age-
specific mortality rates showed an upward trend for per-
sons aged over 50 years (Figure 2b) and a downward trend
for the younger age groups, a rate pattern that corre-
sponds to a cohort effect.
The graphical depiction of the cohort-effect curvature
and its 95% confidence interval (Figure 2d) showed an
increasing risk of death due to pleural cancer, rising to a
maximum in the 1944–1948 cohorts and declining in
subsequent generations. The drop was most pronounced
from the 1956 cohort onwards. The segmented model
detected two points of change in cohort-effect curvature
(p < 0.001), at 1902.63 (95% Confidence Interval (CI)
1899.59-1905.66) and at 1955.21 (95% Confidence Inter-
val (CI) 1953.01-1957.4) (grey lines in Figure 2d, withdashed lines showing the confidence interval). Points of
change in the curvature of the period effect were not
detected.
In women, the number of cases remained fairly stable
over the study period and there was a slight decrease in
age-adjusted rates. The number of estimated cases
among men was 2.7 times higher than that among
women. The shape of the curvature of the cohort effect
(data not shown) in women was similar to that in men,
with a point of change at 1956.47 (95% CI 1949.74-
1963.19), and with no points of change in period-effect
curvature.
The best statistical relationship between the annual per-
capita asbestos imports (AIt) and the annual number of
pleural cancer deaths (PCDt) among men was obtained
from the model with a log link for the mean response and
Figure 2 Age-period-cohort analysis in pleural cancer mortality among men in Spain. Deviance table for age-period-cohort models (a),
trends in age-specific rates by birth cohort (b), cross-sectional age effect for an average period (c), curvature and 95% confidence interval (grey
shadow) of period and cohort effects (d), and change points with 95% confidence intervals in cohort curvature (vertical grey lines).
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a lag period of 36 years, i.e., log{E(PCDt)} = 4.899 +
0.328log(AIt–36), which yielded a minimum AIC of 278.8
and a coefficient of determination of 0.94. Reverting to the
original scale, the asbestos-based prediction model re-
sulted in the power function E(PCDt) = 134.3AIt–36
0.33 . This
model was used to predict the expected annual number of
pleural cancer deaths among men across the upcoming
period 2012–2038.
Shown in Figure 3 are the annual per capita asbestos
imports recorded in Spain for the period 1906–2002
(black circles), along with the pertinent lowess smooth-
ing (black line). The right part of the figure shows the
annual number of pleural cancer deaths in men ob-
served from 1975 to 2011 (black points), with a black
line showing the lowess smoothing of observed (continu-
ous) and predicted (dashed) pleural cancer deaths. Fu-
ture pleural cancer deaths among men, as estimated by
the log model based on asbestos imports, were 145 to
160 deaths/year for the periods 2011–2015 and 2016–2020 respectively. These figures were lower than those
obtained with the APC models (187 and 193 deaths). Es-
timates by five-year period have been added to Table 1
to facilitate comparison.
Discussion
Pleural cancer deaths increased across the study period,
rising from 491 in 1976–1980 to 1,249 in 2006–2010.
Around 1,319 pleural cancer deaths (264 deaths/year)
are predicted for the five-year period 2016–2020. Fore-
casts up to 2020 indicate that this increase will continue,
though the age-adjusted rates already show a trend to-
wards a levelling-off in male mortality from 2001–2005,
a trend corresponding to the lower risk in post-1960
generations. The lower rates and different mortality
trend registered by women would appear to indicate that
occupational exposure is possibly the single factor hav-
ing most influence on this trend.
Previously published predictions [17] estimated that
there would be 636 male pleural cancer deaths (95% CI
Figure 3 Annual raw per capita asbestos imports recorded in Spain from 1906 to 2002 (black circles), together with annual pleural
cancer deaths in men (black points) from 1975 to 2011 and the APC predicted for 2011–2020. Grey line: deaths prediction based on
imports. Black line (left): lowess smoothing of imports. Black line (rigth): lowess smoothing of observed (continuous) and predicted (dashed)
pleural cancer deaths.
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(95% CI 497–960) in the period 2012–2016. Current
data show that in the five-year period 2006–2010 there
were 897 pleural cancer deaths in men, which would
correspond to 642 deaths due to pleural mesothelioma,
assuming a mesothelioma/pleural cancer coefficient of
0.73. In the five-year period 2006–2010, there were ap-
proximately 261 more deaths than the figure predicted
in 2008 (underestimate of 41%).
Unlike other studies [9,15,26], the APC computation
of the prediction did not consider asbestos imports or
their decline from the 1980s until 2002 (the year in
which they came to a halt). The prediction did, however,
consider the decreasing mortality in post-1950 cohorts,
a decrease visible in the age-specific mortality rates and
cohort effect shown in Figure 2. The lag between asbes-
tos imports and pleural cancer deaths shown in Figure 3
(taking the maximum of both series into account) and
confirmed by the modelling strategy, lasted 36 years,
which corresponds to the induction period for meso-
thelioma [27]. Future male pleural cancer mortality esti-
mated by the asbestos import-based model accurately
predicted the increase in pleural cancer deaths until
2008 but predicted a decrease in deaths from 2010
onwards.
The number of pleural cancer deaths among men
predicted for the period 2011–2020 is 1898 under the
APC-based model versus 1680 under the asbestos
import-based model. The import-based model underesti-
mates the deaths observed during 2011. This model
lends excessive weight to the effect of the decline inasbestos imports, as a consequence of the simple statis-
tical relationship established.
Because of the rarity of primary malignant tumours of
the pleura other than mesothelioma, the number of
deaths coded as pleural cancer could be considered a
rough estimate of mesothelioma cases [28]. Mesotheli-
oma mortality estimates and projections are based on
the ratio of pleural mesothelioma mortality to pleural
cancer mortality. Thus, a factor of 0.81 was used in
France to estimate pleural mesothelioma cases from the
total number of pleural cancer deaths [15], and a factor
of 0.73 was used in Italy [9].
From 2006 to 2011, there were 1096 male deaths in
Spain coded as cancer of the pleura, and of these, 849
(77%) were coded as pleural mesotheliomas. In women,
this percentage was 63% (436 pleural cancer deaths, 273
mesotheliomas). If these factors are applied to the
pleural cancer deaths predicted for the period 2016–
2020, then a total of 965 mesothelioma cases (742 in
men and 223 in women) is obtained (193 deaths/year).
The number of mesothelioma deaths predicted for
Spain is lower than that for other countries in the region
[9,15,16]. This is because this country’s asbestos con-
sumption has historically been lower. The use of bulk
asbestos in Spain started in the early 1960s, at a later
date than the rest of Europe. Consumption witnessed a
remarkable increase until 1974, sharing highs in those
years with other European countries. Thenceforth, how-
ever, following the same trend as seen in other countries,
consumption went into a steady decline that continued
until the product’s ban in 2002, with a slight increase at
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one-third lower than that of France and Italy, and half
that of the United Kingdom [7,8].
Spanish records however show far fewer mesothelioma-
related deaths than would have been expected, i.e., 74%
fewer than in France, 79% fewer than in Italy, and 88%
fewer than in the United Kingdom in the year 2000. Sev-
eral hypotheses can be postulated to explain this differ-
ence. Attention to the risks arising from exposure to
asbestos in Spain was almost non-existent until the 1980s,
making it difficult for this diagnosis to be assigned as the
cause of death, in contrast to other countries in the region
[29]. On the other hand, each country’s prevailing eco-
nomic risk activities are decisive, conditioning differences
in asbestos exposure [30,31].
Part of the increase in cases in Spain in the 1990s
could be due to improvements in diagnosis of mesotheli-
oma as a cause of death. It seems more plausible, how-
ever, that this increase is attributable to the effects of
increased asbestos consumption, and that the introduc-
tion of regulatory measures and prohibitions were de-
layed in Spain and that this in turn led to the effects of
exposure being extended.
The first preventive measures targeting asbestos use in
Spain were implemented in 1984 [32] and the ban on
the use, production and marketing of asbestos fibres and
any products containing these was introduced in 2001
[33] and came into effect in December 2002. Subse-
quently, minimum health and safety requirements were
brought in 2006 to cover work entailing a risk of expos-
ure to asbestos [34]. Such work essentially comprises the
removal of installed asbestos, the maintenance, rehabilita-
tion and demolition of buildings with asbestos-containing
materials, and the transport, treatment and destruction of
asbestos-containing waste.
Changes in death-coding criteria can also affect mor-
tality trends. The decline in mortality rates in the five-
year period 1986–1990 and the observed period effect
(Figure 2d) are probably related to coding changes that
took place in Spain at the time (when death-coding du-
ties were transferred to the Autonomous Regions).
Møller’s proposal for estimating future mortality was
used in this study [22]. This method, based on the clas-
sic “generalised linear model” [25], is implemented in
the Norpred package, which has not only been success-
fully used in several European countries [35-37] but has
also been empirically shown to improve prediction valid-
ity [22]. Comparative prediction-quality studies using
different methods have recommended the use of Norpred
in cases such as ours, where there is a cohort effect identi-
fied by age-period-cohort analysis [38].
The disappearance of occupational exposure to asbes-
tos should lead to a reduction in the number of deaths
among men to levels equivalent to those recorded forwomen, which are two thirds lower. Mortality caused by
community exposure to a carcinogenic risk factor such
as asbestos is characterised by a great degree of inertia,
and its catastrophic consequences will persist and re-
main in evidence until the disappearance of the last sur-
viving representatives of the exposed cohorts. To this
must be added the fact that there were no preventive
measures aimed at reducing worker exposure, nor any
emission controls until as late as 1984. It can thus be as-
sumed that occupationally-related deaths due to pleural
mesothelioma will continue to occur in Spain until at
least 2040, bearing in mind the fact that in 2006 the life
expectancy of Spanish men born in the 1960s was
37.4 years. Moreover, account must be taken of the
enormous amount of asbestos which was used in the
construction of buildings (mostly offices, entertainment
venues, public facilities and car parks) from 1965 to
1985 [23] and which will be mobilised for subsequent
demolition or maintenance purposes. Improved educa-
tion regarding protection from exposure during the
demolition or disposal of asbestos-containing material as
well as more adequate measures for reducing risk of
mesothelioma are thus called for [26]. Similarly, the
qualification and training of health care workers in dis-
ease detection and diagnosis must also be improved so
as to ensure that these diseases do not go undetected.Conclusions
Predictions for the five-year period 2016–2020 indicate a
total of 1319 pleural cancer deaths (264 deaths/year).
Forecasts up to 2020 indicate that deaths will continue
to rise, though the age-adjusted rates show a levelling-
off in male mortality from 2001–2005, corresponding to
the lower risk in post-1960 generations. The different
mortality trend registered by women would appear to in-
dicate that occupational exposure is possibly the single
factor having most influence on this trend. The cata-
strophic consequences of human exposure to asbestos
are set to persist and remain in evidence until the last
surviving members of the exposed cohorts have disap-
peared. It can thus be assumed that occupationally-
related deaths due to pleural mesothelioma will continue
to occur in Spain until at least 2040.Competing interests
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